SNOA
Sonoma Pharmaceuticals
$1.20
+$0.06 (+5.26%)Oct 29, 2026
Key metrics
The numbers that frame SNOA today
- Market cap
- $5.75M
- Gross margin
- 38.9%
- EV / Sales
- 0.1
- ROIC
- -33.2%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $0.85
- 52wk High
- $4.06
Growth
Revenue and earnings trend for SNOA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SNOA
Is Sonoma Pharmaceuticals a good buy?
No. Sonoma Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Sonoma Pharmaceuticals is selling at a very high price.
What is the market capitalization of SNOA?
Sonoma Pharmaceuticals's market capitalization is $5.75M.
What is the 52-week high for SNOA stock?
The 52-week high for Sonoma Pharmaceuticals is $4.06. The current close of $1.20 is 70.4% below that high.
What is the 52-week low for SNOA stock?
The 52-week low for Sonoma Pharmaceuticals is $0.85. The current close of $1.20 is 41.2% above that low.
Does SNOA stock pay dividends?
Sonoma Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SNOA?
Sonoma Pharmaceuticals's Debt / Equity ratio is 0.11.